- 询价
- Agrisera
- 瑞典
- AS00 001
- 2025年11月02日
- 1 : 15 000 (I-ELISA), 14 µg/ml (IL)
- Rabbit
- Human
企业认证
相关产品推荐更多 >
Goat anti-Human IgG Fc, min, cross-reactivity to bovine, horse, mouse or rabbit serum proteins or mouse IgG1
询价Donkey anti-Mouse IgG (H&L), F(ab)'2 Fragment, FITC conjugated
询价Goat anti-Human IgM (µ chain), Biotin conjugated, min, cross-reactivity to human IgG; bovine, goat, mouse or rabbit serum proteins
询价
Anti-His-tag | 3xHis (polyclonal) - DyLight® 650 conjugated (40 µg)
询价Guinea Pig anti-Rabbit IgG, FITC conjugated
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant human Factor VIIa (NovoSeven ®, Novo Nordisk A/S Denmark)
- 形态：
Lyophilized in PBS pH 7.4
- 保存条件：
Store lyophilized/reconstituted at -20°C; once rec
- 克隆性：
Polyclonal
- 标记物：
Lopez-Vilchez et al. (2009). Traffic of rFVIIa through Endothelial Cells and Redistribution into Subendothelium: Implications for a Prolonged Hemostatic Effect. Journal of Coagulation Disorders, October 1: (1). (immunolocalization)
- 适应物种：
Human
- 抗原来源：
Q9FI56 , Q9SXJ7
- 级别：
分子生物学级
- 供应商：
Agrisera
- 宿主：
Rabbit
- 应用范围：
1 : 15 000 (I-ELISA), 14 µg/ml (IL)
- 靶点：
Factor VIIa (FVIIa) is a key serine protease involved in the initiation of the coagulation cascade. FVIIa requires tissue factor (TF), a membrane bound protein, as an essential cofactor for maximal activity towards its biological substrates Factor X, Fact
- 抗体英文名：
This antibody is purified using Protein G, to obtain a total IgG fraction.
- 抗体名：
FVIIa | Coagulation factor VIIa (50 µg)
- 规格：
50 µg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Tissue Factor/VIIa in Thrombosis and Cancer
Tissue factor (TF) is a transmembrane glycoprotein that functions as a receptor and cofactor for activated factor VII (factor VIIa) to initiate blood coagulation. Although TF has been characterized best for its role in blood coagulation
Studies on Coagulation Incompatibilities for Xenotransplantation
) circulating PC in the presence of thrombin. Tissue factor pathway inhibitor (TFPI), is the primary inhibitor of tissue factor (TF)-induced coagulation. TFPI directly inhibits the activated factor X (FXa) and blocks the procoagulant activity of the TF/factor
Tissue Factor Pathway Inhibitor in Thrombosis and Beyond
of various diseases. In recent years, tissue-factor pathway inhibitor (TFPI), the only endogenous inhibitor of the TF/FVIIa complex, has been characterized biochemically and pharmacologically. Studies in patients have demonstrated that both TF and TFPI
技术资料暂无技术资料 索取技术资料
